Ray Dalio Codexis, Inc. Transaction History

Bridgewater Associates, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.26 - $6.84 $298 - $478	-70 Reduced 0.37%	18,666 $86,000
Q3 2022 Nov 10, 2022	SELL	$6.06 - $12.86 $5,320 - $11,291	-878 Reduced 4.48%	18,736 $114,000
Q2 2022 Aug 11, 2022	BUY	$8.35 - $21.89 $4,709 - $12,345	564 Added 2.96%	19,614 $205,000
Q1 2022 May 13, 2022	BUY	$16.97 - $31.93 $96,219 - $181,043	5,670 Added 42.38%	19,050 $393,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $342,661 - $559,016	13,380 New	13,380 $418,000

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $274M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.